Stockreport

Intellipharmaceutics Announces Issuance of U.S. and Canadian Patents Covering Aspects of its PODRAS™ Overdose Technology

INTELLIPHARMACEUTICS  (IPCI) 
Last intellipharmaceutics earnings: 10/15 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.intellipharmaceutics.com
PDF TORONTO, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical co [Read more]